Skip to main content
letter
. 2022 Feb 10;107(5):1201–1204. doi: 10.3324/haematol.2021.280516

Table 3.

Clinical features and management of 22 patients with variants of uncertain significance involving EPOR/EGLN1(PHD2)/ EPAS1(HIF2A)/VHL/BPGM and associated erythrocytosis.

graphic file with name 1071201.tab3.jpg